As noted in my March 29 ""Articles of Interest"" post regarding the APC8024 findings as reported at the AACR annual meeting" I thought you may be interested in the APC8024 clinical trial contact information for the University of California San Francisco Comprehensive Cancer Care Center. Dr. Park who comments on APC8024 in the Dendreon press release is located at UCSF. It is my understanding that APC8024 will be heading into Phase II clinical trial testing in the near future.

The cross-link below should take you to the APC8024 clinical trial contact information.